Elanco Animal Health Incorporated (ELAN): Price and Financial Metrics
ELAN Price/Volume Stats
Current price | $15.87 | 52-week high | $16.08 |
Prev. close | $15.78 | 52-week low | $7.88 |
Day low | $15.62 | Volume | 3,618,600 |
Day high | $15.95 | Avg. volume | 5,054,389 |
50-day MA | $14.34 | Dividend yield | N/A |
200-day MA | $11.44 | Market Cap | 7.82B |
ELAN Stock Price Chart Interactive Chart >
ELAN POWR Grades
- Growth is the dimension where ELAN ranks best; there it ranks ahead of 97.57% of US stocks.
- ELAN's strongest trending metric is Value; it's been moving down over the last 26 weeks.
- ELAN ranks lowest in Momentum; there it ranks in the 27th percentile.
ELAN Stock Summary
- With a one year PEG ratio of 0.76, ELANCO ANIMAL HEALTH INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 6.84% of US stocks.
- The price/operating cash flow metric for ELANCO ANIMAL HEALTH INC is higher than 94.15% of stocks in our set with a positive cash flow.
- Over the past twelve months, ELAN has reported earnings growth of -808.87%, putting it ahead of merely 1.74% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to ELANCO ANIMAL HEALTH INC are EBS, ADTH, TEVA, ERJ, and GOCO.
- ELAN's SEC filings can be seen here. And to visit ELANCO ANIMAL HEALTH INC's official web site, go to www.elanco.com.
ELAN Valuation Summary
- ELAN's EV/EBIT ratio is -14.7; this is 200.68% lower than that of the median Healthcare stock.
- ELAN's price/earnings ratio has moved up 34.9 over the prior 64 months.
Below are key valuation metrics over time for ELAN.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
ELAN | 2023-12-29 | 1.7 | 1.2 | -6.4 | -14.7 |
ELAN | 2023-12-28 | 1.7 | 1.2 | -6.4 | -14.7 |
ELAN | 2023-12-27 | 1.7 | 1.2 | -6.4 | -14.6 |
ELAN | 2023-12-26 | 1.7 | 1.2 | -6.4 | -14.6 |
ELAN | 2023-12-22 | 1.7 | 1.2 | -6.3 | -14.5 |
ELAN | 2023-12-21 | 1.6 | 1.2 | -6.2 | -14.4 |
ELAN's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ELAN has a Quality Grade of D, ranking ahead of 16.1% of graded US stocks.
- ELAN's asset turnover comes in at 0.265 -- ranking 169th of 682 Pharmaceutical Products stocks.
- 500 - Internal server error
The table below shows ELAN's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.265 | 0.526 | -0.072 |
2021-03-31 | 0.250 | 0.507 | -0.065 |
2020-12-31 | 0.240 | 0.491 | -0.081 |
2020-09-30 | 0.255 | 0.493 | -0.046 |
2020-06-30 | 0.300 | 0.501 | -0.018 |
2020-03-31 | 0.329 | 0.513 | 0.009 |
Elanco Animal Health Incorporated (ELAN) Company Bio
Elanco Animal Health Incorporated operates as an animal health care company. The Company develops, manufactures, and markets products for companion and food animals. Elanco Animal Health serves clients worldwide. The company is based in Greenfield, Indiana.
Latest ELAN News From Around the Web
Below are the latest news stories about ELANCO ANIMAL HEALTH INC that investors may wish to consider to help them evaluate ELAN as an investment opportunity.
Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceGREENFIELD, Ind., December 19, 2023--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8-10, 2024. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts on Tuesday, January 9, 2024 at 3:00 p.m. PST (6:00 PM EST). |
Elanco Animal Health CEO Targeted by Activist Investor Ancora(Bloomberg) -- Activist investor Ancora has built a position in Elanco Animal Health Inc. and is pushing for leadership changes at the animal-medicine maker, according to people with knowledge of the matter. Most Read from BloombergCiti Shuts Muni Business That Once Was Envy of RivalsOwner of the Philippines’ Largest Malls Says China Feud May Hurt BusinessesRange Rovers Become Thief-Magnets, Causing Prices to TumbleHungary Vetoes Ukraine Aid After EU Agrees on Membership TalksUS Approves New Kin |
Investors in Elanco Animal Health (NYSE:ELAN) from five years ago are still down 61%, even after 8.4% gain this past weekElanco Animal Health Incorporated ( NYSE:ELAN ) shareholders should be happy to see the share price up 19% in the last... |
15 Highest Quality Dog Food To Keep Your Pup Happy and HealthyIn this article, we will be looking at the 15 highest-quality dog food to keep your pup happy and healthy. If you want to skip our detailed analysis, you can go directly to 5 Highest Quality Dog Food To Keep Your Pup Happy and Healthy. The Global Pet Food Industry: An Analysis According to a report by […] |
Elanco to Participate in Evercore ISI 6th Annual HealthCONx ConferenceGREENFIELD, Ind., November 27, 2023--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Evercore ISI 6th Annual HealthCONx Conference, November 28-29, 2023. Todd Young, Executive Vice President and CFO, will participate in a fireside chat on Wednesday, November 29 at 8:20 a.m. ET. |
ELAN Price Returns
1-mo | 2.99% |
3-mo | 48.60% |
6-mo | 30.40% |
1-year | 18.97% |
3-year | -44.22% |
5-year | -46.55% |
YTD | 6.51% |
2023 | 21.93% |
2022 | -56.94% |
2021 | -7.47% |
2020 | 4.14% |
2019 | -6.60% |
Continue Researching ELAN
Want to see what other sources are saying about Elanco Animal Health Inc's financials and stock price? Try the links below:Elanco Animal Health Inc (ELAN) Stock Price | Nasdaq
Elanco Animal Health Inc (ELAN) Stock Quote, History and News - Yahoo Finance
Elanco Animal Health Inc (ELAN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...